Cargando…

Influence of MSI and 18q LOH markers on capecitabine adjuvant monotherapy in colon cancer patients

PURPOSE: The aim of this study was to evaluate whether pretreatment analysis of selected molecular markers can be used for the prediction of disease-free survival (DFS)/overall survival (OS) of capecitabine adjuvant monotherapy in colon cancer patients. PATIENTS AND METHODS: A total of 126 patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Matevska-Geshkovska, Nadica, Staninova-Stojovska, Marija, Kapedanovska-Nestorovska, Aleksandra, Petrushevska-Angelovska, Natalija, Panovski, Milco, Grozdanovska, Biljana, Mitreski, Nenad, Dimovski, Aleksandar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6219100/ https://www.ncbi.nlm.nih.gov/pubmed/30464574 http://dx.doi.org/10.2147/PGPM.S172467

Ejemplares similares

Molecular Basis of Inherited Colorectal Carcinomas in the Macedonian Population: An Update
por: Staninova-Stojovska, M, et al.
Publicado: (2019)

The AKR1D1*36 (rs1872930) Allelic Variant Is Independently Associated With Clopidogrel Treatment Outcome
por: Kapedanovska-Nestorovska, Aleksandra, et al.
Publicado: (2019)

Loss of Y Chromosome in Peripheral Blood of Colorectal and Prostate Cancer Patients
por: Noveski, Predrag, et al.
Publicado: (2016)

Frequencies of single-nucleotide polymorphisms and haplotypes of the SLCO1B1 gene in selected populations of the western balkans
por: Grapci, A Daka, et al.
Publicado: (2015)

Distribution of the most Common Genetic Variants Associated with a Variable Drug Response in the Population of the Republic of Macedonia
por: Kapedanovska Nestorovska, A, et al.
Publicado: (2015)

A novel germline MLH1 mutation causing Lynch Syndrome in patients from the Republic of Macedonia
por: Hiljadnikova-Bajro, Marija, et al.
Publicado: (2012)

The impact of molecular tumor profiling on the design strategies for targeting myeloid leukemia and EGFR/CD44-positive solid tumors
por: Geskovski, Nikola, et al.
Publicado: (2021)

The association of C3435T single-nucleotide polymorphism, Pgp-glycoprotein gene expression levels and carbamazepine maintenance dose in patients with epilepsy
por: Sterjev, Zoran, et al.
Publicado: (2012)

Prevalence of Allelic Variants and Clonality of IGHV1-69 Expressing B-Cells in Patients with Different Severity of COVID 19 Disease
por: Panovska-Stavridis, Irina, et al.
Publicado: (2021)

Evaluation of the JAK2V617F Mutational Burden in Patients with Philadelphia Chromosome Negative Myeloproliferative Neoplasms: A Single-center Experience
por: Popova-Labachevska, M, et al.
Publicado: (2019)

In Reply to Loh and Lin:
por: Vaduganathan, Muthiah, et al.
Publicado: (2014)

Influence of the SCN1A IVS5N + 5 G>A Polymorphism on Therapy with Carbamazepine for Epilepsy
por: Sterjev, Z, et al.
Publicado: (2012)

Dissecting Loss of Heterozygosity (LOH) in Neurofibromatosis Type 1-Associated Neurofibromas: Importance of Copy Neutral LOH
por: Garcia-Linares, Carles, et al.
Publicado: (2011)

Investigation of Cervical Tumor Biopsies for Chromosomal Loss of Heterozygosity (LOH) and Microsatellite Instability (MSI) at the HLA II Locus in HIV-1/HPV Co-infected Women
por: Chambuso, Ramadhani, et al.
Publicado: (2019)

Cost-effectiveness analysis of treating transplant-eligible multiple myeloma patients in Macedonia
por: Qerimi, Vjollca, et al.
Publicado: (2018)

Life Origination Hydrate Hypothesis (LOH-Hypothesis)
por: Ostrovskii, Victor, et al.
Publicado: (2012)

Ixabepilone as Monotherapy or in Combination with Capecitabine for the Treatment of Advanced Breast Cancer
por: Rak Tkaczuk, Katherine H.
Publicado: (2011)

An integrated Bayesian analysis of LOH and copy number data
por: Rancoita, Paola MV, et al.
Publicado: (2010)

2022 ISCB Overton Prize: Po-Ru Loh
por: Fogg, Christina, et al.
Publicado: (2022)

Cost-effectiveness analysis of capecitabine monotherapy versus capecitabine plus oxaliplatin in elderly patients with advanced gastric cancer
por: Peng, Jingyuan, et al.
Publicado: (2018)

Capecitabine Monotherapy as Palliative Treatment for Patients with Recurrent/Metastatic Nasopharyngeal Cancer
por: Alshamsan, Bader, et al.
Publicado: (2022)

Direct Inference of SNP Heterozygosity Rates and Resolution of LOH Detection
por: Li, Xiaohong, et al.
Publicado: (2007)

Hook Wire Localization Procedure and Early Detection of Breast Cancer - Our Experience
por: Dimitrovska, Maja Jakimovska, et al.
Publicado: (2015)

Tolerability of Capecitabine Monotherapy in Metastatic Colorectal Cancer: A Real-World Study
por: Leicher, Laura W., et al.
Publicado: (2016)

Loss of heterozygosity (LOH), malignancy grade and clonality in microdissected prostate cancer
por: Hügel, A, et al.
Publicado: (1999)

Darwinian rebel: The legacy of Loh-Seng Tsai—Chinese animal psychologist
por: Wang, Yong, et al.
Publicado: (2021)

Preoperative chemoradiotherapy with capecitabine and triweekly oxaliplatin versus capecitabine monotherapy for locally advanced rectal cancer: a propensity-score matched study
por: Li, Anchuan, et al.
Publicado: (2022)

Colorectal Carcinogenesis: MSI-H Versus MSI-L
por: Pawlik, Timothy M., et al.
Publicado: (2004)

Response of Meningeal Carcinomatosis from Breast Cancer to Capecitabine Monotherapy: A Case Report
por: Tanaka, Yumi, et al.
Publicado: (2013)

Contribution of retinoblastoma LOH and the p53 Arg/Pro polymorphism to cervical cancer
por: ELTAHIR, HUDA A., et al.
Publicado: (2012)

Evaluation of statin utilization in the Republic of Macedonia during 2013–2016
por: Naumovska, Zorica, et al.
Publicado: (2018)

Evaluation of the Directly Observed Treatment’s Acceptance by Tuberculosis Patients in the Republic of Macedonia
por: Ilievska-Poposka, Biljana, et al.
Publicado: (2018)

LOH at 3p correlates with a poor survival in oral squamous cell carcinoma.
por: Partridge, M., et al.
Publicado: (1996)

Integration of transcript expression, copy number and LOH analysis of infiltrating ductal carcinoma of the breast
por: Hawthorn, Lesleyann, et al.
Publicado: (2010)

Identifying Human Genome-Wide CNV, LOH and UPD by Targeted Sequencing of Selected Regions
por: Wang, Yu, et al.
Publicado: (2015)

LOH at 1p31 (ARHI) and Proliferation in Lymph Node-Negative Breast Cancer
por: Janssen, Emiel A. M., et al.
Publicado: (2009)

Integrated investigation of the prognostic role of HLA LOH in advanced lung cancer patients with immunotherapy
por: Zhang, Xiaotao, et al.
Publicado: (2022)

Phase II trial of utidelone as monotherapy or in combination with capecitabine in heavily pretreated metastatic breast cancer patients
por: Zhang, Pin, et al.
Publicado: (2016)

Real‐world evidence of adjuvant gemcitabine plus capecitabine vs gemcitabine monotherapy for pancreatic ductal adenocarcinoma
por: de Jong, Evelien J. M., et al.
Publicado: (2021)

Breast cancer in young women: prevalence of LOH at p53, BRCA1 and BRCA2
por: Johnson, SM, et al.
Publicado: (2000)

Cannot write session to /tmp/vufind_sessions/sess_i94tg7nclpml336auqfjlf1nb1